missing translation for 'onlineSavingsMsg'
Learn More
Learn More
(2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid), Mikromol™
Description
(2RS)-2-Hydroxy-2-phenylacetic Acid (Mandelic Acid)
Specifications
Specifications
| Chemical Name or Material | DL-Mandelic Acid |
| CAS | 90-64-2 |
| Analyte or Component Names | DL-Mandelic Acid |
| Shipping Condition | Room Temperature |
| Molecular Formula | C8 H8 O3 |
| Certifications/Compliance | ISO 17034 |
| Synonym | Glycopyrronium Bromide Imp. C (EP), Homatropine Methylbromide Imp. C (EP), Pregabalin Imp. C (EP), Sertraline Hydrochloride Imp. E (EP), Sertraline Imp. E (EP), (2RS)-2-Hydroxy-2-phenylacetic Acid, Hydroxyphenylacetic Acid, Mandelic Acid, Sertraline Hydrochloride Imp. E (EP) as Racemate, Mandelic acid, (RS)-2-Hydroxy-2-phenylacetic acid, (RS)-Mandelic acid, (+/-)-2-Hydroxy-2-phenylethanoic acid, (+/-)-Mandelic acid, (+/-)-alpha-Hydroxybenzeneacetic acid, (+/-)-alpha-Hydroxyphenylacetic acid, 2-Hydroxy-2-phenylacetic acid, 2-Phenyl-2-hydroxyacetic acid, 2-Phenylglycolic acid, Almond acid, Amygdalic acid, DL-Amygdalic acid, DL-Hydroxy(phenyl)acetic acid, DL-Mandelic acid, NSC 7925, Paramandelic acid, Phenylglycolic acid, Phenylhydroxyacetic acid, Uromaline, dl-Mandelic acid, alpha-Hydroxy-alpha-toluic acid, alpha-Hydroxybenzeneacetic acid, alpha-Hydroxyphenylacetic acid, Glycopyrronium Bromide Impurity C, Homatropine Methylbromide Impurity C, Pregabalin Impurity C, Sertraline Hydrochloride Impurity E as Racemate, Glycopyrronium Impurity C, Sertraline Impurity E as Racemate |
| InChI Formula | InChI=1S/C8H8O3/c9-7(8(10)11)6-4-2-1-3-5-6/h1-5,7,9H,(H,10,11) |
| SMILES | OC(C(=O)O)c1ccccc1 |
| IUPAC Name | 2-hydroxy-2-phenylacetic acid |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?